MMC clinical trials

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

This study looks at a new treatment called TAR-210 for a type of bladder cancer. It compares TAR-210 with standard chemotherapy to see which is better at keeping the cancer away.